Found 16 matching trials
Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma PHASE1 RATIONALE: Radioactive substances, such as samarium 153, may release radiat...
Show More Location
Comprehensive Blood and Cancer Center
Learn More & Join Trial
Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer PHASE1 RATIONALE: Bone marrow transplantation may allow the doctor to give higher ...
Show More Location
Louisiana State University School of Medicine
Learn More & Join Trial
Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma PHASE2 RATIONALE: Radioactive drugs, such as samarium Sm 153 lexidronam pentasodiu...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer PHASE2 RATIONALE: Giving samarium Sm 153 lexidronam pentasodium and 3-dimensional ...
Show More Location
Arizona Oncology Services Foundation
Learn More & Join Trial
Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain PHASE1 RATIONALE: Radioactive drugs, such as samarium Sm 153 lexidronam pentasodiu...
Show More Learn More & Join Trial
Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer PHASE1 The purpose of this study is to determine the safety and effectiveness of S...
Show More Location
Thomas Jefferson University
Learn More & Join Trial
Effect of Samarium on the Relief of Pain Due to Vertebral Metastases PHASE1 Cancer cells may spread from the primary site to the vertebrae resulting in...
Show More Location
New York Methodist Hospital
Learn More & Join Trial
Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer PHASE1 The primary objective of the study is to determine a recommended phase II d...
Show More Location
The Harry and Jeanette Weinberg Building
Learn More & Join Trial
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer PHASE1 The purpose of this study is to investigate the safety, tolerability and an...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma PHASE1 RATIONALE: Radioactive drugs, such as samarium Sm 153 lexidronam pentasodiu...
Show More Location
Mayo Clinic Scottsdale
Learn More & Join Trial